dc.contributor.author | Hernández Martínez, Paula | es_ES |
dc.contributor.author | Olmos Martínez, José Manuel | es_ES |
dc.contributor.author | Llorca Díaz, Francisco Javier | es_ES |
dc.contributor.author | González Macías, Jesús | es_ES |
dc.contributor.author | Hernández Hernández, José Luis | es_ES |
dc.contributor.other | Universidad de Cantabria | es_ES |
dc.date.accessioned | 2023-05-22T18:05:30Z | |
dc.date.available | 2023-05-22T18:05:30Z | |
dc.date.issued | 2022 | es_ES |
dc.identifier.issn | 1862-3522 | es_ES |
dc.identifier.issn | 1862-3514 | es_ES |
dc.identifier.uri | https://hdl.handle.net/10902/29047 | |
dc.description.abstract | Summary
The associations of sarcopenia with osteoporosis or obesity have a very low prevalence. No trend towards an association between osteoporosis and sarcopenia is observed. Sarcopenia and obesity tend not to coincide, as if they were antagonistic disorders.
Purpose
To know (a) the prevalence in our region of sarcopenic osteoporosis (association of sarcopenia and osteoporosis (T-score<2.5)), sarcopenic obesity, and the association of osteoporosis, sarcopenia, and obesity; (b) the tendency of osteoporosis, sarcopenia, and obesity to associate with each other; and (c) the bone mineral density (BMD), the components of sarcopenia, and the prevalence of fragility fractures in these associations.
Methods
The study was performed in the Camargo cohort. Osteoporosis was diagnosed by DXA, sarcopenia by the EWGSOP-1 criteria, and obesity by body mass index (BMI) and fat percentage. Fractures were verified radiographically or by consulting the medical records.
Results
The prevalence of sarcopenic osteoporosis was 2.8% and the OR for this association 1.03 (p=0.89). The prevalence of sarcopenic obesity by BMI was 1.4% and by fat percentage 5.9% (corresponding ORs: 0.18 (p<0.0001) and 0.58 (p<0.003) respectively). The prevalence of the association of osteoporosis, sarcopenia, and obesity was 0.0% when assessed by BMI and 0.8% when assessed by fat percentage. Patients with sarcopenic osteoporosis have less muscle mass and more fragility fractures than sarcopenic patients overall. In patients with sarcopenic obesity by fat percentage, muscle mass and strength, as well as physical performance, were similar to those of sarcopenic patients overall. Neither BMD nor fracture prevalence showed differences between patients with sarcopenic obesity and patients with sarcopenia or obesity in general.
Conclusion
Our study supports the idea that the prevalence of the mixed disorders studied is low. No significant association between osteoporosis and sarcopenia was found. Sarcopenia and obesity seem to tend to occur in different people, as if suffering from one of them hinders suffering from the other. | es_ES |
dc.description.sponsorship | Funding: Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This study was funded by grants from
the Instituto de Salud Carlos III (PI18/00762), Ministerio de Economía y Competitividad, Spain, which included FEDER funds from the EU. | es_ES |
dc.format.extent | 10 p. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Springer | es_ES |
dc.rights | Attribution 4.0 International | * |
dc.rights | © The Author(s) 2022 | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.source | Archives of Osteoporosis (2022) 17:105 | es_ES |
dc.subject.other | Osteoporosis | es_ES |
dc.subject.other | Sarcopenia | es_ES |
dc.subject.other | Obesity | es_ES |
dc.subject.other | Sarcopenic osteoporosis | es_ES |
dc.subject.other | Sarcopenic obesity | es_ES |
dc.title | Sarcopenic osteoporosis, sarcopenic obesity, and sarcopenic osteoporotic obesity in the Camargo cohort (Cantabria, Spain) | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherVersion | https://doi.org/10.1007/s11657-022-01146-1 | es_ES |
dc.rights.accessRights | openAccess | es_ES |
dc.identifier.DOI | 10.1007/s11657-022-01146-1 | es_ES |
dc.type.version | publishedVersion | es_ES |